| Literature DB >> 35456239 |
Igor Lazic1, Florian Hinterwimmer1,2, Severin Langer1, Florian Pohlig1, Christian Suren1, Fritz Seidl3, Daniel Rückert2, Rainer Burgkart1, Rüdiger von Eisenhart-Rothe1.
Abstract
BACKGROUND: Machine Learning (ML) in arthroplasty is becoming more popular, as it is perfectly suited for prediction models. However, results have been heterogeneous so far. We hypothesize that an accurate ML model for outcome prediction in THA must be able to compute arthroplasty-specific data. In this study, we evaluate a ML approach applying data from two German arthroplasty-specific registries to predict adverse outcomes after THA, after careful evaluations of ML algorithms, outcome and input variables by an interdisciplinary team of data scientists and surgeons.Entities:
Keywords: artificial intelligence; hip surgery; machine learning; supervised learning; total hip arthroplasty
Year: 2022 PMID: 35456239 PMCID: PMC9032696 DOI: 10.3390/jcm11082147
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Description of input parameters.
|
|
| ||
|---|---|---|---|
|
| |||
|
| EndoCert/EPRD | ||
| Male | 545 | 44.8% | |
| Female | 672 | 55.2% | |
|
| EndoCert/EPRD | ||
| Primary osteoarthritis | 817 | 67.1% | |
| Dysplasia | 129 | 10.6% | |
| Femoral neck fracture | 16 | 1.3% | |
| Femoral head necrosis | 80 | 6.6% | |
| Posttraumatic osteoarthritis | 46 | 3.8% | |
| Tumour/metastasis | 129 | 10.6% | |
|
| EndoCert/EPRD | ||
| Left | 590 | 48.5% | |
| Right | 627 | 51.5% | |
|
| EPRD | ||
| Primary implant | 932 | 76.6% | |
| Revision implant | 231 | 19.0% | |
| Tumour implant | 54 | 4.4% | |
|
| EndoCert | ||
| Surgeon 1 | 20 | 1.6% | |
| Surgeon 2 | 1 | 0.1% | |
| Surgeon 3 | 92 | 7.6% | |
| Surgeon 4 | 317 | 26.0% | |
| Surgeon 5 | 6 | 0.5% | |
| Surgeon 6 | 1 | 0.1% | |
| Surgeon 7 | 62 | 5.1% | |
| Surgeon 8 | 43 | 3.5% | |
| Surgeon 9 | 1 | 0.1% | |
| Surgeon 10 | 2 | 0.2% | |
| Surgeon 11 | 10 | 0.8% | |
| Surgeon 12 | 8 | 0.7% | |
| Surgeon 13 | 96 | 7.9% | |
| Surgeon 14 | 216 | 17.7% | |
| Surgeon 15 | 182 | 15.0% | |
| Surgeon 16 | 89 | 7.3% | |
| Surgeon 17 | 71 | 5.8% | |
|
| |||
|
| EndoCert | ||
| 1 Resident | 17 | 1.4% | |
| 2 Fellow | 111 | 9.1% | |
| 3 Attending-Junior | 1 | 0.1% | |
| 4 Attending—Main Surgeon * | 199 | 16.4% | |
| 5 Attending—Senior Surgeon * | 889 | 73.0% | |
|
| EndoCert/EPRD | ||
| 2016 | 324 | 26.6% | |
| 2017 | 394 | 32.4% | |
| 2018 | 282 | 23.2% | |
| 2019 | 217 | 17.8% | |
|
| |||
| Age | 67 | 13.8 | EndoCert/EPRD |
| Height (in cm) | 170 | 88.0 | EPRD |
| Weight (in kg) | 80 | 17.4 | EPRD |
| BMI | 23 | 11.7 | EPRD |
* “Attending—Main Surgeon” corresponds to “Hauptoperateur” (>50 operation per year) and “Attending—Senior Surgeon” corresponds to “Senior-Hauptoperateur” (>100 operation per year) as defined by Endocert; Body Mass Index (BMI), Endoprothesenregister Deutschland (EPRD).
Distribution of outcome labels.
|
|
| ||
|---|---|---|---|
| Complications | 161 | (13.2%) | EndoCert |
| Irregular duration of surgery | 267 | (21.9%) | EndoCert |
Figure 1Flowchart describing training and testing datasets.
Figure 2Correlation matrix of input parameters.
Figure 3AUC ROC and feature importance for complication prediction. (A) Machine Learning algorithm for complication prediction (green), AUC ROC = 0.64, (B) feature importance of the prediction model; AUC ROC = area under the curve receiver operating characteristics. BMI, body mass index.
Figure 4AUC ROC and feature importance for prediction of irregular surgery duration. (A) Machine Learning algorithm for irregular surgery prediction (green), AUC ROC = 0.89, (B) feature importance of the prediction model; AUC ROC = area under the curve receiver operating characteristics. BMI, body mass index.
Outcome metrics for the prediction models of complications and irregular surgery duration.
| Prediction of | Accuracy | Sensitivity | Specificity | AUC * |
|---|---|---|---|---|
| Complications | 80.3 | 31.0 | 89.4 | 64.1 |
| Irregular Duration | 81.7 | 58.2 | 91.6 | 89.1 |
* AUC = area under the receiver operating curve.